Evidence map›Paper›PMID 27914109›Full record

ArticleGenes, chromosomes & cancer2017

BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.

Yu-Chien Kao, Yun-Shao Sung, Lei Zhang, Samuel Kenan, Samuel Singer, William D Tap, David Swanson, Brendan C Dickson, Cristina R Antonescu

Open access · greenAbstract readCase Reports
In one paragraph

Article in Genes, chromosomes & cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Expanding the Clinicopathologic Spectrum of EWSR1::SSX-Rearranged Sarcomas: Series of 11 Cases Including Osteosarcomas and a Novel EWSR1::SSX4 Fusion.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Identification of novel SSX1 fusions in synovial sarcoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Yu-Chien KaoDepartment of Pathology, Shuang Ho Hospital, Taipei Medical University, Taiwan.
Yun-Shao SungDepartment of Pathology, Memorial Sloan Kettering Cancer Center, NY.
Lei ZhangDepartment of Pathology, Memorial Sloan Kettering Cancer Center, NY.
Samuel KenanDepartment of Surgery, Long Island Jewish Medical Center, New Hyde Park, NY.
Samuel SingerDepartment of Surgery, Memorial Sloan Kettering Cancer Center, NY.
William D TapDepartment of Medicine, Memorial Sloan Kettering Cancer Center, NY.
David SwansonDepartment of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
Brendan C DicksonDepartment of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
Cristina R AntonescuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, NY.
Memorial Sloan Kettering Cancer Center · USMount Sinai Hospital · CALong Island Jewish Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
SPORE in Soft Tissue SarcomaP50CA140146 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SPRIGGS, DAVID R · 2010 to 2014
$11.1M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA140146
6 · The paper itself

Abstract

The diagnosis of poorly differentiated synovial sarcoma (PD-SS) may be challenging due to overlapping morphologic features with other undifferentiated round cell sarcomas (URCS). Particularly relevant is the histologic overlap and shared BCOR overexpression between a subset of SS and URCS with various BCOR genetic abnormalities. Here, we report a case of PD-SS lacking the canonical SS18-SSX gene fusion, but showing strong BCOR immunoreactivity and BCOR gene abnormalities by FISH, which were misinterpreted as a URCS with BCOR gene rearrangements. The tumor had an unusual clinical presentation arising as an intraneural tumor in the ankle of a 29-year-old female. The tumor displayed a mixture of fascicular spindle cells and undifferentiated round cell components. FISH studies showed no SS18 gene abnormality; however, RNA sequencing identified a fusion transcript involving SS18L1 (a paralog gene of SS18 at 20q13.33) and SSX1. Further FISH testing validated rearrangements in SSX1 and SS18L1 genes, in addition to complex structural abnormalities of the Xp11.22-4 region. This is the second reported SS case harboring an SS18L1-SSX1 alternative fusion variant, similarly occurring in association with a large nerve. The lack of SS18 gene rearrangements by FISH corroborated with the BCOR overexpression at both mRNA and protein level may result in diagnostic pitfalls with URCS with BCOR gene abnormalities. Our results further suggest that BCOR upregulation is emerging as a common downstream pathway for SS with either typical SS18-SSX transcript or with rare fusion variants, such as SS18L1-SSX. © 2017 Wiley Periodicals, Inc.

Indexed as

Cell DifferentiationAdultFemaleHumansNeoplasm ProteinsOncogene Proteins, FusionPrognosisProto-Oncogene ProteinsRepressor ProteinsSarcoma, SynovialTrans-ActivatorsTranscriptional ActivationUp-RegulationBCOR protein, humanNeoplasm ProteinsOncogene Proteins, FusionProto-Oncogene ProteinsRepressor ProteinsSS18L1 protein, humansynovial sarcoma X breakpoint proteinsTrans-Activators

Identifiers

PMID27914109
PMCPMC5546405
OpenAlexW2560563682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.